AB Corporate Bond ETF (NASDAQ:EYEG) Short Interest Down 88.1% in August

AB Corporate Bond ETF (NASDAQ:EYEG) was the recipient of a large decline in short interest in the month of August. As of August 14th, there was short interest totaling 78 shares, a decline of 88.1% from the July 30th total of 655 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 861 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Investors Weigh In On AB Corporate Bond ETF

A hedge fund recently raised its stake in AB Corporate Bond ETF stock. Jane Street Group LLC increased its position in shares of AB Corporate Bond ETF (NASDAQ:EYEG) by 166.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,741 shares of the specialty pharmaceutical company’s stock after buying an additional 9,839 shares during the period. Jane Street Group LLC owned 2.10% of AB Corporate Bond ETF worth $563,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 64.16% of the company’s stock.

AB Corporate Bond ETF Trading Down 0.0%

Shares of EYEG stock traded down $0.01 on Friday, hitting $34.70. The company had a trading volume of 170 shares, compared to its average volume of 277. The firm has a market cap of $27.76 million, a P/E ratio of -20.65 and a beta of 0.18. The stock’s 50-day moving average is $34.83 and its two-hundred day moving average is $35.20. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07. AB Corporate Bond ETF has a twelve month low of $34.46 and a twelve month high of $36.63.

AB Corporate Bond ETF Increases Dividend

The company also recently declared a monthly dividend, which was paid on Thursday, August 6th. Shareholders of record on Monday, August 3rd were issued a dividend of $0.1427 per share. This represents a c) annualized dividend and a yield of 4.9%. The ex-dividend date was Monday, August 3rd. This is a positive change from AB Corporate Bond ETF’s previous monthly dividend of $0.14. AB Corporate Bond ETF’s dividend payout ratio (DPR) is -102.38%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.